Literature DB >> 28501377

Structural Changes Associated with Delayed Dark Adaptation in Age-Related Macular Degeneration.

Inês Laíns1, John B Miller2, Dong H Park3, Edem Tsikata4, Samaneh Davoudi2, Safa Rahmani2, Jonathan Pierce2, Rufino Silva5, Teresa C Chen4, Ivana K Kim2, Demetrios Vavvas2, Joan W Miller2, Deeba Husain6.   

Abstract

PURPOSE: To examine the relationship between dark adaptation (DA) and optical coherence tomography (OCT)-based macular morphology in age-related macular degeneration (AMD).
DESIGN: Prospective, cross-sectional study. PARTICIPANTS: Patients with AMD and a comparison group (>50 years) without any vitreoretinal disease.
METHODS: All participants were imaged with spectral-domain OCT and color fundus photographs, and then staged for AMD (Age-related Eye Disease Study system). Both eyes were tested with the AdaptDx (MacuLogix, Middletown, PA) DA extended protocol (20 minutes). A software program was developed to map the DA testing spot (2° circle, 5° superior to the fovea) to the OCT B-scans. Two independent graders evaluated the B-scans within this testing spot, as well as the entire macula, recording the presence of several AMD-associated abnormalities. Multilevel mixed-effects models (accounting for correlated outcomes between 2 eyes) were used for analyses. MAIN OUTCOME MEASURES: The primary outcome was rod-intercept time (RIT), defined in minutes, as a continuous variable. For subjects unable to reach RIT within the 20 minutes of testing, the value of 20 was assigned.
RESULTS: We included 137 eyes (n = 77 subjects), 72.3% (n = 99 eyes) with AMD and the remainder belonging to the comparison group. Multivariable analysis revealed that even after adjusting for age and AMD stage, the presence of any abnormalities within the DA testing spot (ß = 4.8, P < 0.001), as well as any abnormalities in the macula (ß = 2.4, P = 0.047), were significantly associated with delayed RITs and therefore impaired DA. In eyes with no structural changes within the DA testing spot (n = 76, 55.5%), the presence of any abnormalities in the remaining macula was still associated with delayed RITs (ß = 2.00, P = 0.046). Presence of subretinal drusenoid deposits and ellipsoid zone disruption were a consistent predictor of RIT, whether located within the DA testing spot (P = 0.001 for both) or anywhere in the macula (P < 0.001 for both). Within the testing spot, the presence of classic drusen or serous pigment epithelium detachment was also significantly associated with impairments in DA (P ≤ 0.018).
CONCLUSIONS: Our results suggest a significant association between macular morphology evaluated by OCT and time to dark-adapt. Subretinal drusenoid deposits and ellipsoid zone changes seem to be strongly associated with impaired dark adaptation.
Copyright © 2017 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28501377     DOI: 10.1016/j.ophtha.2017.03.061

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  17 in total

1.  Characterization of Rod Function Phenotypes Across a Range of Age-Related Macular Degeneration Severities and Subretinal Drusenoid Deposits.

Authors:  Oliver J Flynn; Catherine A Cukras; Brett G Jeffrey
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-05-01       Impact factor: 4.799

2.  Sub-threshold nanosecond laser (SNL) treatment in intermediate AMD (IAMD).

Authors:  R Theodore Smith
Journal:  Ann Eye Sci       Date:  2019-01-10

3.  Biomarkers for Nonexudative Age-Related Macular Degeneration and Relevance for Clinical Trials: A Systematic Review.

Authors:  Vivienne Fang; Maria Gomez-Caraballo; Eleonora M Lad
Journal:  Mol Diagn Ther       Date:  2021-08-25       Impact factor: 4.074

4.  Active Learning of Contrast Sensitivity to Assess Visual Function in Macula-off Retinal Detachment.

Authors:  Merina Thomas; Rebecca F Silverman; Filippos Vingopoulos; Megan Kasetty; Gina Yu; Esther L Kim; Amro A Omari; Katherine A Joltikov; Eun Y Choi; Leo A Kim; David N Zacks; John B Miller
Journal:  J Vitreoretin Dis       Date:  2020-11-05

5.  Rod-Mediated Dark Adaptation and Macular Pigment Optical Density in Older Adults with Normal Maculas.

Authors:  Anna V Zarubina; Carrie E Huisingh; Mark E Clark; Kenneth R Sloan; Gerald McGwin; Jason N Crosson; Christine A Curcio; Cynthia Owsley
Journal:  Curr Eye Res       Date:  2018-05-01       Impact factor: 2.424

6.  The ARMS2 A69S Polymorphism Is Associated with Delayed Rod-Mediated Dark Adaptation in Eyes at Risk for Incident Age-Related Macular Degeneration.

Authors:  Robert F Mullins; Gerald McGwin; Karen Searcey; Mark E Clark; Elizabeth L Kennedy; Christine A Curcio; Edwin M Stone; Cynthia Owsley
Journal:  Ophthalmology       Date:  2018-10-31       Impact factor: 12.079

7.  BASELINE PREDICTORS ASSOCIATED WITH 3-YEAR CHANGES IN DARK ADAPTATION IN AGE-RELATED MACULAR DEGENERATION.

Authors:  Ines Lains; Shrinivas J Pundlik; Archana Nigalye; Raviv Katz; Gang Luo; Ivana K Kim; Demetrios G Vavvas; Joan W Miller; John B Miller; Deeba Husain
Journal:  Retina       Date:  2021-10-01       Impact factor: 3.975

Review 8.  Epigenetic Treatment of Neurodegenerative Ophthalmic Disorders: An Eye Toward the Future.

Authors:  Walter H Moos; Douglas V Faller; Ioannis P Glavas; David N Harpp; Michael H Irwin; Iphigenia Kanara; Carl A Pinkert; Whitney R Powers; Kosta Steliou; Demetrios G Vavvas; Krishna Kodukula
Journal:  Biores Open Access       Date:  2017-12-01

9.  Natural History of Rod-Mediated Dark Adaptation over 2 Years in Intermediate Age-Related Macular Degeneration.

Authors:  Cynthia Owsley; Mark E Clark; Gerald McGwin
Journal:  Transl Vis Sci Technol       Date:  2017-06-05       Impact factor: 3.283

10.  Higher Intake of Polyunsaturated Fatty Acid and Monounsaturated Fatty Acid is Inversely Associated With AMD.

Authors:  Miin Roh; Hyun Joon Shin; Inês Laíns; Joana Providência; Maria Caseiro-Alves; Patrícia Barreto; Demetrios G Vavvas; John B Miller; Ivana K Kim; John Michael Gaziano; Liming Liang; Rufino Silva; Joan W Miller; Deeba Husain
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-02-07       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.